AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 79 filers reported holding AKCEA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,299,000 | +149.8% | 71,598 | +88.6% | 0.01% | +100.0% |
| Q2 2020 | $520,000 | +356.1% | 37,956 | +376.1% | 0.00% | +300.0% |
| Q1 2020 | $114,000 | -29.2% | 7,972 | +40.4% | 0.00% | 0.0% |
| Q1 2019 | $161,000 | +38.8% | 5,677 | +47.6% | 0.00% | 0.0% |
| Q4 2018 | $116,000 | -4.1% | 3,846 | -44.7% | 0.00% | 0.0% |
| Q4 2017 | $121,000 | – | 6,951 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 100,000 | $1,736,000 | 1.13% |
| BB BIOTECH AG | 1,248,650 | $21,677,000 | 0.61% |
| Virtus ETF Advisers LLC | 18,071 | $314,000 | 0.39% |
| Eventide Asset Management | 420,000 | $7,291,000 | 0.38% |
| Granahan Investment Management | 194,376 | $3,374,000 | 0.26% |
| ALTRINSIC GLOBAL ADVISORS LLC | 150,000 | $2,604,000 | 0.10% |
| Candriam S.C.A. | 114,571 | $1,990,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 15,000 | $260,000 | 0.03% |
| Delpha Capital Management, LLC | 1,521 | $26,000 | 0.03% |
| FMR LLC | 9,981,244 | $173,274,000 | 0.02% |